Stocktoria
Inmune Bio, Inc. INMB
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-02-04
Inmune Bio, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 812,895 | $7.2M | 3.06% |
| AQR CAPITAL MANAGEMENT LLC | 662,218 | $1.1M | 2.49% |
| MILLENNIUM MANAGEMENT LLC | 159,559 | $260,081 | 0.6% |
| CITADEL ADVISORS LLC | 123,031 | $200,541 | 0.46% |
| RENAISSANCE TECHNOLOGIES LLC | 29,700 | $48,411 | 0.11% |
| Point72 Asset Management, L.P. | 16,577 | $27,021 | 0.06% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.